Medicinálny Tekutý Kyslík Air Products (Oxygen)

Oxygen, the active ingredient in Medicinálny Tekutý Kyslík Air Products, is a medical gas presented as a liquid oxygen for inhalation use. It treats hypoxemia, respiratory distress and carbon monoxide poisoning in patients who require supplemental oxygen.

GNH USA supplies Medicinálny Tekutý Kyslík Air Products as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Medicinálny Tekutý Kyslík Air Products provides supplemental oxygen for conditions characterized by low blood‑oxygen levels.

- Hypoxemia: raises arterial oxygen tension to improve tissue oxygenation. - Respiratory distress: supports breathing effort and reduces work of breathing. - Carbon monoxide poisoning: displaces carbon monoxide from hemoglobin and restores oxygen delivery.

Supplemental oxygen can cause a range of reactions, from mild irritation to serious toxicity.

Common Side Effects: - Nasal dryness or irritation. - Mild headache. - Cough or throat discomfort. - Fatigue or drowsiness. - Nausea.

Serious or Rare Side Effects: - Pulmonary oxygen toxicity (reduced lung compliance, inflammation). - Fire hazard due to increased oxygen concentration. - Central nervous system toxicity with prolonged high‑concentration exposure. - Visual disturbances (blurred vision) in rare cases. - Seizures related to severe hyperoxia.

Oxygen therapy requires careful monitoring and adherence to safety guidelines.

- Assess patient oxygen saturation before and during therapy: use pulse oximetry to guide flow rates. - Avoid open flames, smoking, or flammable materials near the delivery system. - Use appropriate delivery devices (nasal cannula, mask) as prescribed. - Limit high‑concentration exposure (>60% FiO2) to short periods unless medically indicated. - Ensure equipment is inspected regularly for leaks or damage. - Store at ambient temperature: keep cylinders in a well‑ventilated, dry area away from direct sunlight and heat sources.

Oxygen can interact with certain substances, influencing safety and efficacy.

Major Interactions (Avoid): - Smoking or open flames: dramatically increase fire risk. - Volatile anesthetic gases (e.g., sevoflurane, isoflurane): heightened combustion potential. - Nitrous oxide: may enhance fire hazard when combined with high‑flow oxygen.

Moderate Interactions (Monitor Closely): - Certain chemotherapeutic agents (e.g., bleomycin): may increase pulmonary toxicity risk. - Antioxidant supplements (vitamin C, E): theoretical risk of altered oxidative balance; monitor patient response.